Fingerprint
Dive into the research topics of 'BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer
Michael J. Pishvaian, Andrew V. Biankin, Peter Bailey, David K. Chang, Daniel Laheru, Christopher L. Wolfgang, Jonathan R. Brody
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations